Research from University of Texas MD Anderson Cancer Center Broadens Understanding of Mesotheliomas (Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural ...)

Source :: Health & Medicine Week. July 19, 2024, p5145.
Publication Year :: 2024
Abstract: 2024 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in mesotheliomas. According to news reporting out of the [...]

Subjects :: University of Texas. M.D. Anderson Cancer Center
Oncology, Experimental
Clinical trials -- Research
Cancer -- Research
Pharmaceutical industry -- Research
Bayer HealthCare Pharmaceuticals

Tools